Published

Psilocybin-assisted therapy for depression: How do we advance the field?

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Australian and New Zealand journal of psychiatry
Date: 2020-03-01
Source: PubMed
DOI: 10.1177/0004867419888575
PubMed: 31752499

Authors

Meikle SE Liknaitzky P Rossell SL Ross M Strauss N Thomas N Murray G Williams M Castle DJ

Watch author

Derived topics and classifications

psilocybin Depression Mechanism of Action Adverse Events Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-assisted therapy for depression: How do we advance the field?2020-03-01

Related papers

The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-26 Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.ClinicalTrials.gov · 2025-11-19 Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 The psychedelic experience and treatment-resistant depressionWorld Psychiatry · 2023-09-15 The psychedelic renaissance: can psilocybin possibly combat depression?International Journal of Surgery Global Health · 2022-11-01 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30